SCHEMBL25580599

SCHEMBL25580599

c1ccc(-c2ccccc2-c2c(-c3ccccc3)cccc2-c2ccc(N(c3ccc(-c4ccc5ccccc5c4)cc3)c3cccc4oc5ccccc5c34)cc2)cc1

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ANO1 Q5XXA6 1/20 0.33
▸ GPR84 Q9NQS5 3/20 0.32
▸ PLA2G2A P14555 3/20 0.32
▸ PLA2G4A P47712 3/20 0.32
▸ HSD17B1 P14061 2/20 0.32
▸ HSD17B2 P37059 2/20 0.32
▸ PGR P06401 1/20 0.32
▸ ALDH1A1 P00352 2/20 0.32
▸ MAPT P10636 1/20 0.32
▸ CRHR1 P34998 1/20 0.31
▸ CA12 O43570 1/20 0.31
▸ CA1 P00915 1/20 0.31
▸ CA2 P00918 1/20 0.31
▸ CA9 Q16790 1/20 0.31
▸ ESR1 P03372 2/20 0.31
▸ ESR2 Q92731 2/20 0.31
▸ PLA2G10 O15496 1/20 0.31
▸ KDM4E B2RXH2 1/20 0.30
▸ MAOB P27338 1/20 0.30
▸ RAB9A P51151 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25580887 0.96 GPR84 (0.32) ANO1GPR84PLA2G2APLA2G4APGR
SCHEMBL25580747 0.96 GPR84 (0.31) ANO1GPR84HSD17B1HSD17B2ALDH1A1
SCHEMBL25580254 0.95 HSD17B1 (0.33) ANO1GPR84PLA2G2APLA2G4AHSD17B1
SCHEMBL25578888 0.95 ANO1 (0.34) ANO1GPR84PLA2G2APLA2G4AHSD17B1
SCHEMBL25578903 0.95 ANO1 (0.34) ANO1GPR84PLA2G2APLA2G4AHSD17B1
SCHEMBL25580650 0.95 ALDH1A1 (0.32) GPR84ALDH1A1MAPTCRHR1KDM4E
SCHEMBL24841359 0.95 PLA2G2A (0.36) ANO1GPR84PLA2G2APLA2G4AHSD17B1
SCHEMBL23179568 0.95 PLA2G2A (0.36) ANO1GPR84PLA2G2APLA2G4AHSD17B1
SCHEMBL22255329 0.93 PGR (0.36) ANO1PLA2G2APLA2G4AHSD17B1HSD17B2
SCHEMBL25579450 0.93 ANO1 (0.34) ANO1GPR84PLA2G2APLA2G4AHSD17B1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230180597-A1 COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENTS, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE IDEMITSU KOSAN CO.,LTD. (JP) 2023-06-08 — — US disclosed
US-20230180597-A1 COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENTS, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE IDEMITSU KOSAN CO.,LTD. (JP) 2023-06-08 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230180597-A1 COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENTS, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE ESR1, L1CAM, ESR2 ANO1 324/4885GPR84 2791/4885PLA2G2A 2335/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback